News Trends, News Analysis, News Archive.



Related Articles

politicsNews reuters.com

Republican Moore embraces Trump message on eve of Alabama election

BIRMINGHAM, Ala. (Reuters) - Republican U.S. Senate candidate Roy Moore touted his ties to President Donald Trump on Monday in the final stretch of an election campaign in Alabama in which Moore has battled accusations of sexual misconduct toward teenagers.

companyNews reuters.com

BRIEF-Trico Bancshares Enters San Francisco Bay Area With Acquisition Of FNB Bancorp

* ENTERS SAN FRANCISCO BAY AREA WITH ACQUISITION OF FNB BANCORP

healthNews reuters.com

Air pollution fine particles linked to poor sperm quality

(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.

domesticNews reuters.com

U.S. judge warns of mistrial in Nevada rancher Bundy's trial

LAS VEGAS (Reuters) - A U.S. federal judge in the criminal conspiracy trial of Nevada rancher Cliven Bundy and three other men on Monday warned that prosecutors' failure to produce documents that could support defense arguments could lead to a mistrial.

healthNews reuters.com

Retirement linked to longer, better sleep

(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.

companyNews reuters.com

BRIEF-Bookrunner Says Detsky Mir Final Deal Size Expected To Be 46.5mm Shares in accelerated bookbuilt offering

* BLOCK TRADE - DETSKY MIR: BOOKRUNNER SAYS TRANSACTION EXPECTED TO PRICE AT RUB 90 PER SHARE; FINAL DEAL SIZE EXPECTED TO BE 46.5MM SHARES AT THIS PRICE‍​ Further company coverage:

companyNews reuters.com

BRIEF-Agios Pharmaceuticals Presents New Safety Data From Study on Leukemia Drug

* PRESENTS NEW SAFETY DATA FROM PHASE 1 EXPANSION STUDY EVALUATING ORAL IVOSIDENIB IN PATIENTS WITH R/R AML AND IDH1 MUTATION

healthNews reuters.com

Amgen's Kyprolis improves overall survival in blood cancer patients

(Reuters) - Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.

healthNews reuters.com

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.

healthNews reuters.com

Breast reconstruction after cancer less common at cash-strapped hospitals

(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

cnn.com

Secret message apps on the rise at work

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

businessNews reuters.com

Ryanair pilots in Dublin vote in favor of industrial action

DUBLIN (Reuters) - Pilots employed directly by Ryanair in Dublin, its second largest base, have voted overwhelmingly in favor of taking industrial action in a growing dispute over the airline's collective bargaining system, the IMPACT trade union said on Monday.

cnn.com

Drug trial shows promising results to fight Huntington's disease

For the first time, an experimental drug has reduced levels of the toxic protein that causes Huntington's disease in humans.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

UPDATE 1-'Ground-breaking' new drug gives hope in Huntington's disease

LONDON, Dec 11 (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Suning Commerce sells 5.5 mln shares in Alibaba, expects net income of 3.25 bln yuan

* SAYS IT EXPECTS NET INCOME OF 3.25 BILLION YUAN ($491.16 million) AFTER SELLING 5.5 MILLION SHARES IN ALIBABA GROUP HOLDING Source text in Chinese: http://bit.ly/2B32uI0 Further company coverage: ($1 = 6.6170 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

cnn.com

Teen has a blunt message for Aetna

healthNews reuters.com

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.

healthNews reuters.com

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

healthNews reuters.com

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

businessNews reuters.com

Bitcoin futures rocket past $18,000; Asian shares buoyant

SYDNEY (Reuters) - The craze for cryptocurrencies entered a new chapter on Monday as bitcoin futures rocketed by one-fifth of their value at a hotly anticipated launch, while Asian shares climbed amid optimism about global growth.

companyNews reuters.com

GLOBAL MARKETS-Bitcoin futures rocket past $18,000; Asian shares buoyant

* Fed expected to hike rates this week; BoE, ECB also meeting

healthNews reuters.com

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

businessNews reuters.com

Bitcoin futures surge past $18,000; Asian shares firm

SYDNEY (Reuters) - The craze for cryptocurrencies entered a new chapter on Monday as bitcoin futures rocketed by one-fifth of their value at a closely-watched launch, while Asian shares climbed amid optimism about global growth.

companyNews reuters.com

GLOBAL MARKETS-Bitcoin futures surge past $18,000; Asian shares firm

* Fed expected to hike rates this week; BoE, ECB also meeting

sportsNews reuters.com

Ice hockey brothers first bans after NZ drug probe

WELLINGTON (Reuters) - Two brothers who played ice hockey for New Zealand have become the first athletes to be banned after an investigation into the sale of performance-enhancing drugs to amateur sportspeople in the country.

Terrorism nytimes.com

How ISIS Produced Its Cruel Arsenal on an Industrial Scale

When the Islamic State seized territory in Iraq and Syria, it had the time and space to industrialize advanced weapons manufacturing. The results included explosive space heaters and chemical rockets.

healthNews reuters.com

Hospital operators in merger talks to form U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.

healthNews reuters.com

Hospital operators in merger talks to create U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.

healthNews reuters.com

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.

healthNews reuters.com

France orders international recall of Lactalis baby formula

PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.

healthNews reuters.com

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

companyNews reuters.com

Gilead's new drug keeps 56 pct of lymphoma trial patients alive

Dec 10 (Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival-study

Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

politicsNews reuters.com

Democrats eye gains in Pennsylvania trial on 'goofy' gerrymandering

LOWER MERION, Pa. (Reuters) - In Pennsylvania state Senator Daylin Leach's bid to win a seat vital to the Democratic Party's chances in 2018 elections of taking control of the U.S. Congress, his opponents may not be his biggest obstacle.

cnn.com

Trump stays on message during controversial civil rights museum visit

President Donald Trump honored civil rights heroes and local officials during remarks at the opening of a civil rights museum in Mississippi on Saturday, staying on message despite recent criticisms of his appearance there.

Drugs (Pharmaceuticals) nytimes.com

Prescription Drugs May Cost More With Insurance Than Without It

Some consumers are finding they can get a better deal on prescription drugs by leaving their insurance cards at home.

companyNews reuters.com

Drug industry group sues to stop California drug price law

Dec 8 (Reuters) - The trade group representing U.S. drugmakers on Friday said it has a filed a lawsuit to stop California from implementing a law aimed at reining in prescription drug prices.

healthNews reuters.com

U.S. House committee 'may reconsider' WHO cancer agency funds

LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.

healthNews reuters.com

Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

UPDATE 1-Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

BRIEF-Leap Therapeutics Files For Resale Of Up To 3.73 Mln Shares Of Co's Common Stock By Selling Stockholders

* LEAP THERAPEUTICS INC FILES FOR RESALE OF UP TO 3.73 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (http://bit.ly/2jdjIfs) Further company coverage:

companyNews reuters.com

BRIEF-Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder

* SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: (http://bit.ly/2BQ55m2) Further company coverage:

healthNews reuters.com

Lilly's Cyramza meets main goal in gastric cancer study

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

healthNews reuters.com

Depression in late teens linked to high school drop out

(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.

politicsNews reuters.com

Mueller turns over evidence for ex-Trump campaign manager Manafort's trial

WASHINGTON (Reuters) - U.S. Special Counsel Robert Mueller has turned over more than 400,000 emails, financial records and other documents to defense attorneys for President Donald Trump's former campaign manager Paul Manafort to demonstrate what evidence the government has against him, according to a court filing on Friday.

companyNews reuters.com

CANADA STOCKS-TSX posts 2-week high as industrials lead broad-based rally

TORONTO, Dec 8 (Reuters) - Canada's main stock index rose to a two-week high on Friday, led by financial and industrial shares after solid U.S. jobs data boosted investor sentiment, while energy stocks climbed on higher oil prices.

healthNews reuters.com

Kids who get moving may also get better grades

(Reuters Health) - Students who get extra physical activity may pay more attention in school and do better in subjects like reading and math, a research review suggests.

healthNews reuters.com

Acupressure app may help ease menstrual cramp pain

(Reuters Health) - Women with intense menstrual cramp pain may get more relief from smartphone app-guided acupressure than with typical medical treatments like painkillers, a recent study suggests.

Fires and Firefighters nytimes.com

A Rite of Passage for a Los Angeles Mayor: A Natural Disaster

The fires in Los Angeles are a test not only for the city but for its mayor, Eric Garcetti.

companyNews reuters.com

BRIEF-Lombard Odier Asset Management Owns About 9.85% Issued & Outstanding Ordinary Shares Of Horizonte Minerals As At Dec 8

* LOMBARD ODIER ASSET MANAGEMENT - AS AT DEC 8, CO HAS OWNERSHIP OF ABOUT 9.85% OF ISSUED & OUTSTANDING ORDINARY SHARES OF HORIZONTE MINERALS Source text for Eikon: Further company coverage:

healthNews reuters.com

Credibility, recipes, references help food blogs improve eating habits

(Reuters Health) - Consumers like healthy eating blogs written by nutritionists who seem credible and who interact with their readers, a small study in Canada suggests.

companyNews reuters.com

BRIEF-KKR Has Brought Its Tender Offer For Shares Of Hitachi Kokusai Electric To A Close - Nikkei‍​

* KOHLBERG KRAVIS ROBERTS HAS BROUGHT ITS TENDER OFFER FOR SHARES OF HITACHI KOKUSAI ELECTRIC TO A CLOSE - NIKKEI‍​

businessNews reuters.com

Steinhoff shares climb off 14-year low in volatile trade

JOHANNESBURG (Reuters) - Steinhoff shares plunged another 50 percent on Friday, before paring some losses as traders booked profits on short positions taken out after the South African retailer disclosed accounting irregularities earlier this week.

Salami nytimes.com

Trilobites: Actually, You Do Want to Know How This Sausage Gets Made

Starter bacteria used in salami made by industrial manufacturers is safer, but results in less flavorful dried sausage than the artisanal process.

healthNews reuters.com

Uganda says it has contained an outbreak of Marburg hemorrhagic fever

KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.

companyNews reuters.com

BRIEF-Aevi Genomic Medicine Files For Resale Of Up To 26.2 Mln Shares Of Co's Common Stock By Selling Stockholders

* AEVI GENOMIC MEDICINE INC FILES FOR RESALE OF UP TO 26.2 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text - http://bit.ly/2kEddlX Further company coverage:

healthNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

companyNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in Phase III study

Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

healthNews reuters.com

Top Russian pork producer Miratorg reports ASF outbreak

MOSCOW (Reuters) - Russia's largest pork producer Miratorg on Friday reported an outbreak of African Swine Fever (ASF) at one of its sites in the Belgorod region in central Russia.

sportsNews reuters.com

Peru's Guerrero to miss World Cup after drugs ban

(Reuters) - Peru's hopes at next year's World Cup finals were dealt a huge blow when captain and all-time record goalscorer Paolo Guerrero was banned for one year on Friday after failing an anti-doping test for cocaine.

businessNews reuters.com

Roche, Novartis' Italian heads risk trial for alleged market rigging: sources

ROME (Reuters) - The local heads of Swiss drugmakers Roche and Novartis risk facing trial in Italy for alleged market manipulation, judicial sources said on Friday.

businessNews reuters.com

Steinhoff shares bounce off 14-year low in volatile trade

JOHANNESBURG (Reuters) - Steinhoff shares plunged another 50 percent on Friday, before recovering as traders booked profits on short positions taken out after the South African retailer disclosed accounting irregularities earlier this week.

healthNews reuters.com

Venezuela's chronic shortages give rise to 'medical flea markets'

SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.

healthNews reuters.com

Russia's meat firm Miratorg reports ASF outbreak at 1 site in Russia

MOSCOW (Reuters) - Russian privately-owned meat producer Miratorg said on Friday there was an outbreak of African Swine Fever (ASF) at one of its sites in Russia's Belgorod region.

sportsNews reuters.com

FIFA bans Peru skipper Guerrero for one year for drug offence

ZURICH (Reuters) - FIFA's disciplinary committee has banned Peruvian soccer captain Paulo Guerrero for one year after he failed a doping test, the watchdog said on Friday.

companyNews reuters.com

BRIEF-Giga Media Ltd CEO Cheng-Ming Huang Reports Open Market Purchase Of 55,070 Shares Of Co's Common Stock On Dec 6 At $2.9375 Per Share

* GIGA MEDIA LTD CEO CHENG-MING HUANG REPORTS OPEN MARKET PURCHASE OF 55,070 SHARES OF CO'S COMMON STOCK ON DEC 6 AT $2.9375PER SHARE - SEC FILING‍​ Source text: [http://bit.ly/2yOQita] Further company coverage:

worldNews reuters.com

Trial over 'Love Parade' deaths begins in Germany

BERLIN (Reuters) - Ten people went on trial in Germany on Friday for alleged failures in planning the "Love Parade" music festival in 2010 when 21 people were killed and more than 650 injured in a stampede.

healthNews reuters.com

Philippines to seek refund of $59 million from Sanofi amid vaccine risk

MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.

worldNews reuters.com

Vatican should bring money-laundering cases to trial, watchdog agency says

VATICAN CITY (Reuters) - The Vatican needs to bring cases of suspected money laundering to trial, a European finance watchdog urged on Friday, saying the good progress made by its financial regulators needed to be matched by judicial muscle.

healthNews reuters.com

Roche study finds cancer 'Velcro' that halts T-cell attack

ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.

healthNews reuters.com

U.S. Department of Justice investigating fetal tissue transfers

(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.

healthNews reuters.com

U.S. Department of Justice seeks documents on fetal tissue transfers

(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.

Drug Abuse and Traffic nytimes.com

A Comeback for the Gateway Drug Theory?

As marijuana legalization and the opioid epidemic sweep across the country, new research is breathing fresh life into the perennial debate.

companyNews reuters.com

BRIEF-Tellurian Prices Public offering of 10.0 Mln Common Shares At $10/Share

* TELLURIAN ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

businessNews reuters.com

Japanese shares rally, bitcoin shoots for the moon

SYDNEY (Reuters) - Asian shares rallied for a second session on Friday as investors awaited major economic data from China and the United States while marveling at the meteoric ascent of the market's new crypto-star, bitcoin.

companyNews reuters.com

GLOBAL MARKETS-Japanese shares rally, bitcoin shoots for the moon

SYDNEY, Dec 8 (Reuters) - Asian shares rallied for a second session on Friday as investors awaited major economic data from China and the United States while marvelling at the meteoric ascent of the market's new crypto-star, bitcoin.

companyNews reuters.com

BRIEF-Seritage - ‍Priced Public Offering Of 2.8 Mln Shares Of 7.00% Series A Cumulative Redeemable Preferred Shares

* SERITAGE GROWTH PROPERTIES PRICES PUBLIC OFFERING OF 7.00% SERIES A PREFERRED SHARES

healthNews reuters.com

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.

cnn.com

Trial date set for AT&T, Time Warner case

companyNews reuters.com

BRIEF-Medicinova Announces Positive Top-Line Results From Clinical Trial Of MN-166 (ibudilast) In ALS

* MEDICINOVA ANNOUNCES POSITIVE TOP-LINE RESULTS FROM THE CLINICAL TRIAL OF MN-166 (IBUDILAST) IN ALS

companyNews reuters.com

BRIEF-Clarke Inc Says Co To Commence Offer To Purchase 1.3 Mln Of Outstanding Common Shares At Purchase Price Of $10.50 Per Share In Cash

* CLARKE INC - CO TO COMMENCE OFFER TO PURCHASE 1.3 MILLION OF ITS OUTSTANDING COMMON SHARES AT A PURCHASE PRICE OF $10.50 PER SHARE IN CASH Source text for Eikon: Further company coverage:

companyNews reuters.com

BRIEF-Party City Announces Secondary Offering Of 10 mln Shares By Selling Stockholders

* PARTY CITY ANNOUNCES SECONDARY OFFERING OF 10,000,000 SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS AND REPURCHASE OF COMMON STOCK Source text for Eikon: Further company coverage:

companyNews reuters.com

UPDATE 3-AT&T/Time Warner antitrust trial set for March

WASHINGTON, Dec 7 (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19 with no decision expected before the companies' April 22 deadline to complete the deal, a federal judge said on Thursday.

healthNews reuters.com

Childhood cancer survivors have more blood pressure problems

(Reuters Health) - More than one in 12 adult survivors of childhood cancers may have undiagnosed high blood pressure, a U.S. study suggests.

businessNews reuters.com

AT&T/Time Warner antitrust trial set for March

WASHINGTON (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19, a federal judge in Washington said during a hearing on Thursday.

companyNews reuters.com

UPDATE 2-AT&T/Time Warner antitrust trial set for March

WASHINGTON, Dec 7 (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19, a federal judge in Washington said during a hearing on Thursday.

healthNews reuters.com

Faulty positioning in rugby tackles boosts injury risk

(Reuters Health) - Head, neck and shoulder injuries during rugby tackles are more common when the tackler’s head is incorrectly positioned in relation to the ball carrier, a small study has found.

businessNews reuters.com

LendingClub shares take a hit from disappointing forecast

(Reuters) - Shares of LendingClub Corp hit a record low on Thursday after the online lender raised its loss estimate and cut its revenue forecast for the fourth quarter.

healthNews reuters.com

Gum infections tied to increased risk of stomach cancer precursor

(Reuters Health) - Gum infections may increase people’s risk for sores in the digestive tract that can lead to stomach cancer, a small study suggests.

healthNews reuters.com

Open windows and doors can improve sleep quality

(Reuters Health) - Leaving a bedroom door or window open may help people sleep better, a study from the Netherlands suggests.

healthNews reuters.com

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.

companyNews reuters.com

BRIEF-Quanterix Corp Shares Debut 8.3 pct Above IPO Price

* QUANTERIX CORP SHARES OPEN AT $16.25 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $15.00 PER SHARE Further company coverage:

companyNews reuters.com

UPDATE 3-Sage shares surge as depression drug succeeds in mid-stage trial

* Shares surge as much as 85 pct (Adds details on drug's mechanism, analyst comment, updates shares)

companyNews reuters.com

UPDATE 5-Roche drug cocktail doubles chance of holding lung cancer at bay

* Analysts see drug sales topping $4.6 bln by 2023 - poll (Adds analyst comment)

healthNews reuters.com

South African egg prices seen rising 20 percent after avian flu outbreak

JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.

healthNews reuters.com

More than 2,000 drugs now in cancer immunotherapy race

LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

healthNews reuters.com

Sage shares surge as depression drug succeeds mid-stage trial

(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.

companyNews reuters.com

BRIEF-Dicerna Announces First Human Dosed In Phase 1 Clinical Trial Of DCR-PHXC

* DICERNA ANNOUNCES FIRST HUMAN DOSED IN PHASE 1 CLINICAL TRIAL OF DCR-PHXC FOR TREATMENT OF ALL FORMS OF PRIMARY HYPEROXALURIA

companyNews reuters.com

GLOBAL MARKETS-Dollar hits two-week high, world shares climb as risk appetite returns

LONDON, Dec 7 (Reuters) - The dollar rose to its highest level in two weeks on Thursday and world shares rebounded amid a broader recovery in global risk sentiment.

healthNews reuters.com

Sage's depression drug succeeds in mid-stage study, shares soar

(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

companyNews reuters.com

UPDATE 1-Sage's depression drug succeeds in mid-stage study, shares soar

Dec 7 (Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

companyNews reuters.com

BRIEF-Orange is ready to buy back shares from French state-CEO

* ORANGE CEO STEPHANE RICHARD SAYS GROUP READY TO EXAMINE BUYING BACK SOME OF THE SHARES OWNED BY FRENCH STATE

businessNews reuters.com

AT&T/Time Warner antitrust hearing to focus on trial date

WASHINGTON (Reuters) - The U.S. Department of Justice and AT&T Inc will meet in court for the first time on Thursday as the antitrust regulator attempts to stop the U.S. No. 2 wireless company's $85 billion purchase of media company Time Warner Inc .

healthNews reuters.com

Indonesia fights 'extraordinary' diphtheria outbreak that has killed 32

JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.

companyNews reuters.com

UPDATE 3-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

businessNews reuters.com

Dollar hits two-week high on U.S. tax reform optimism, world shares climb

LONDON (Reuters) - The dollar rose to its highest level in two weeks on Thursday over optimism the United States would successfully push through tax reforms, while world shares rebounded after two straight days of losses.

companyNews reuters.com

GLOBAL MARKETS-Dollar hits 2-week high on U.S. tax reform optimism, world shares climb

LONDON, Dec 7 (Reuters) - The dollar rose to its highest level in two weeks on Thursday over optimism the United States would successfully push through tax reforms, while world shares rebounded after two straight days of losses.

worldNews reuters.com

Pro-Kurdish opposition leader goes on trial in Turkey on terror-related charges

ANKARA (Reuters) - The jailed leader of Turkey's pro-Kurdish opposition went on trial on Thursday, 13 months after his arrest on terrorism-related charges, facing up to 142 years in prison in a case closely watched by rights groups and Western governments.

companyNews reuters.com

UPDATE 2-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

companyNews reuters.com

BRIEF-Interoil: Canacol Energy Sells 1.4 Mln Shares In Company

* CANACOL ENERGY LTD SELLS 1.4 MILLION SHARES IN INTEROIL AT A PRICE OF NOK 2.2 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

businessNews reuters.com

Asia shares creep above 2-month lows, but growth, U.S. policy risks weigh

TOKYO (Reuters) - Asian shares hovered above two-month lows on Thursday as some high-tech bellwethers bounced back after a searing sell-off although softer oil and copper prices and uncertainty over U.S. policy kept many investors cautious.

companyNews reuters.com

GLOBAL MARKETS-Asia shares creep above 2-mth lows, but growth, US policy risks weigh

TOKYO, Dec 7 (Reuters) - Asian shares hovered above two-month lows on Thursday as some high-tech bellwethers bounced back after a searing sell-off although softer oil and copper prices and uncertainty over U.S. policy kept many investors cautious.

companyNews reuters.com

UPDATE 1-Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

companyNews reuters.com

Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

companyNews reuters.com

BRIEF-Quanterix Prices IPO Of 4.28 Mln Shares At $15 Per Share

* SAYS INITIAL PUBLIC OFFERING OF 4.28 MILLION COMMON SHARES PRICED AT $15.00PER SHARE Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )

businessNews reuters.com

Asia shares hover near 2-month low as growth, U.S. policy risks weigh

TOKYO (Reuters) - Asian shares hovered near two-month lows on Thursday as softer oil and copper prices and uncertainty over U.S. policy kept many investors on the sidelines, even as some high-tech bellwethers bounced back after a searing sell-off.

companyNews reuters.com

GLOBAL MARKETS-Asia shares hover near 2-mth low as growth, US policy risks weigh

* Ex-Japan Asia little changed despite rebound in some tech names

companyNews reuters.com

BRIEF-At Home Group Prices Secondary Offering Of 5 Mln Shares At $24.5 Per Share

* AT HOME ANNOUNCES PRICING OF SECONDARY PUBLIC OFFERING OF COMMON STOCK

businessNews reuters.com

Asia shares hover near two-month low as growth, U.S. policy risks sap sentiment

TOKYO (Reuters) - Asian shares held close to a two-month low on Thursday as softer oil and copper as well as U.S. policy uncertainty kept sentiment in check, while high-tech stocks struggled to recover after a searing sell-off.

companyNews reuters.com

GLOBAL MARKETS-Asia shares hover near 2-mth low as growth, US policy risks sap sentiment

TOKYO, Dec 7 (Reuters) - Asian shares held close to a two-month low on Thursday as softer oil and copper as well as U.S. policy uncertainty kept sentiment in check, while high-tech stocks struggled to recover after a searing sell-off.

companyNews reuters.com

UPDATE 2-Lululemon forecasts upbeat holiday quarter, shares rise 7 pct

* Holiday-quarter sales expectation beats estimates (Adds conference call details, analyst comments; updates share move)

healthNews reuters.com

Knee surgery outcomes linked with education level

(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.

companyNews reuters.com

BRIEF-First Bancshares Announces Acquisition Of Sunshine Financial

* THE FIRST BANCSHARES, INC. ANNOUNCES THE ACQUISITION OF SUNSHINE FINANCIAL, INC.

healthNews reuters.com

Study confirms higher breast cancer risk with hormone-based contraception

(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.

companyNews reuters.com

UPDATE 1-Lululemon forecasts upbeat holiday quarter, shares rise

Dec 6 (Reuters) - Canadian yoga and leisure apparel maker Lululemon Athletica Inc on Wednesday reported a higher-than-expected profit and gave an upbeat holiday-quarter forecast, sending its shares up 6 percent in after-hours trading.

healthNews reuters.com

U.S. healthcare spending growth slowed in 2016

(Reuters) - Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act, a government health agency reported on Wednesday.

healthNews reuters.com

Home births in rural areas just as safe as in cities

(Reuters Health) - Home births may not be more dangerous for healthy rural mothers than for their urban counterparts, a recent U.S. study suggests.

companyNews reuters.com

BRIEF-Aptiv Plc's CEO Kevin Clark Reports Open Market Purchase Of 22,500 Shares Of Co's Common Stock

* APTIV PLC'S CEO KEVIN CLARK REPORTS OPEN MARKET PURCHASE OF 22,500 SHARES OF CO'S COMMON STOCK ON DECEMBER 6 AT AVERAGE PRICE OF $87.88PER SHARE - SEC FILING Source text - (http://bit.ly/2zUlaq0) Further company coverage:

healthNews reuters.com

Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) - After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

cnn.com

Kamala Harris' message for Franken

Sen. Kamala Harris (D-CA) calls on Sen. Al Franken (D-MN) to to leave office as allegations of sexual harassment against him continue to mount.

healthNews reuters.com

Kids aren’t protecting themselves against STDs during oral sex

(Reuters Health) - Adolescents and young adults regularly engage in oral sex but seldom use condoms to prevent the spread of sexually transmitted diseases, new research shows.

healthNews reuters.com

FDA proposes drug development guidance for rare pediatric diseases

(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.

healthNews reuters.com

Sign-ups pick up in week five of 2018 Obamacare open enrollment - U.S.

WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.

companyNews reuters.com

CANADA STOCKS-TSX falls as Hudson's Bay shares slump

TORONTO, Dec 6 (Reuters) - Canada's main stock index fell in early trade on Wednesday, hurt by a tumble in shares of Hudson's Bay Co after the department store operator posted a wider-than-expected quarterly loss, while financial and energy stocks also weighed.

companyNews reuters.com

BRIEF-Ferroglobe Plc Updates On Open-Market Purchases Of Co's Shares By Its Senior Management

* FERROGLOBE PLC UPDATES ON OPEN-MARKET PURCHASES OF CO'S SHARES BY ITS SENIOR MANAGEMENT

healthNews reuters.com

Myanmar's opium crop plummets, but no victory over Asia's narco-boom: U.N.

BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.

companyNews reuters.com

BRIEF-Novo Nordisk expects to launch new diabetes drug in Japan during H1 2018

Dec 6 (Reuters) - NOVO NORDISK A/S CHIEF SCIENTIFIC OFFICER MADS KROGSGAARD THOMSEN MADE FOLLOWING COMMENTS DURING AN INVESTOR CALL FOLLOWING U.S. APPROVAL OF DIABETES DRUG OZEMPIC:

companyNews reuters.com

CORRECTED-Delivery Hero to place up to $810 million worth of shares

FRANKFURT, Dec 5 (Reuters) - Delivery Hero, the world's largest online takeaway food delivery group, said on Tuesday it would offer shares worth up to 686 million euros ($810 million) to investors, raking in cash to expand its business through takeovers.

companyNews reuters.com

BRIEF-‍$11.1 Million Sale By Genesis Of Two Sites In Sage Meadows​

* ‍$11.1 MILLION SALE BY GENESIS OF TWO SITES IN SAGE MEADOWS​

healthNews reuters.com

GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

companyNews reuters.com

REFILE-Gold trader says he never liked Turkish banker facing trial

(Refiles to add dropped text in final two paragraphs.) By Brendan Pierson NEW YORK, Dec 5 (Reuters) - A Turkish gold trader testifying for U.S. prosecutors in the trial of an executive at Turkey's state-owned Halkbank, who is charged with helping Iran evade U.S. sanctions, said Tuesday that he and the banker never liked each other. Reza Zarrab, who has pleaded guilty and is cooperating with U.S. prosecutors in the case, also said he had complained about Halkbank deputy ge

healthNews reuters.com

Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

companyNews reuters.com

BRIEF-Webster Financial Corpo Announces Pricing Of Public Offering Of 6 Million Depositary Shares

* WEBSTER FINANCIAL CORPORATION ANNOUNCES PRICING OF PUBLIC OFFERING OF SIX MILLION DEPOSITARY SHARES REPRESENTING INTERESTS IN PREFERRED STOCK

healthNews reuters.com

Consistently lower cancer survival rates for black patients in U.S.

(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.

cnn.com

Sen. Jeff Flake writes a check to Democrat opposing Roy Moore with the message, 'Country over Party'

Republican Sen. Jeff Flake, who's been adamantly opposed to Republican Alabama Senate hopeful Roy Moore, posted a photo Tuesday of a check with his signature on it that was addressed to Moore's Democratic rival, Doug Jones.

healthNews reuters.com

Brazil, U.S. identify molecule to help fight citrus greening disease

SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.

domesticNews reuters.com

Gold trader says he never liked Turkish banker facing trial

NEW YORK (Reuters) - A Turkish gold trader testifying for U.S. prosecutors in the trial of an executive at Turkey's state-owned Halkbank, who is charged with helping Iran evade U.S. sanctions, said Tuesday that he and the banker never liked each other.

healthNews reuters.com

Paraguay Congress legalizes planting of medical marijuana

ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.

healthNews reuters.com

Eating almonds with chocolate may lower cholesterol

(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who don’t consume these foods, a recent experiment suggests.

healthNews reuters.com

Hospital patients are safe with substitute doctors

(Reuters Health) - Hospital patients’ survival rates don’t suffer when fill-in doctors substitute for the regular staff physicians, a U.S. study suggests.

companyNews reuters.com

UPDATE 2-U.S. FDA approves Novo Nordisk diabetes drug Ozempic

Dec 5 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co's Trulicity.

companyNews reuters.com

Delivery Hero to place $810 million worth of shares

FRANKFURT, Dec 5 (Reuters) - Delivery Hero, the world's largest online takeaway food delivery group, said on Tuesday it would offer shares worth 686 million euros ($810 million) to investors, raking in cash to expand its business through takeovers.

healthNews reuters.com

Women get mixed messages about sexuality after childbirth

(Reuters Health) - Women receive mixed messages about the ways giving birth may affect their sex lives, according to a new report.

healthNews reuters.com

FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated competitive battle with Eli Lilly & Co's Trulicity.

companyNews reuters.com

UPDATE 2-European shares slip in cyclical-defensive tug of war

* Investors reach for consumer staples, utilities (Adds closing prices)

healthNews reuters.com

Galectin slumps after NASH drug misses main goal of mid-stage trial

(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.

healthNews reuters.com

Shire in deal to develop a new way to administer hemophilia drug

(Reuters) - Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

sportsNews reuters.com

Olympics: IOC sees more than 20,000 drugs tests in Pyeongchang lead-up

LAUSANNE, Switzerland (Reuters) - More than 20,000 doping tests will have been conducted by the start of next year's Pyeongchang winter Olympics as the International Olympic Committee's pre-Games testing program hopes to root out cheats in advance, it said on Tuesday.

healthNews reuters.com

Galectin says NASH drug misses main goal of midstage trial

(Reuters) - Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a midstage trial.

healthNews reuters.com

Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.

companyNews reuters.com

BRIEF-Revance’s RT002 Meets Primary, Secondary Endpoints In Sakura Phase 3 Trials

* REVANCE’S RT002 MEETS PRIMARY AND ALL SECONDARY ENDPOINTS, ACHIEVES 6-MONTH DURATION IN PIVOTAL SAKURA PHASE 3 TRIALS FOR GLABELLAR LINES

companyNews reuters.com

BRIEF-Actinium Pharmaceuticals Says Phase 2 Clinical Trial Planned For 2018 For Actimab-MDS​

* ACTINIUM PHARMACEUTICALS UNVEILS ACTIMAB-MDS AND PLANNED PHASE 2 TRIAL IN MYELODYSPLASTIC SYNDROMES TARGETED AT PATIENTS WITH HIGH-RISK P53+ GENETIC MUTATIONS

healthNews reuters.com

WHO backs Philippines suspension of Sanofi's dengue vaccine

GENEVA (Reuters) - The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi's dengue drug Dengvaxia, the WHO said in a statement.

companyNews reuters.com

UPDATE 1-European shares slip in cyclical-defensive tug of war

* Investors reach for consumer staples, utilities (ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

companyNews reuters.com

European shares steady as tech-financials rotation continues

LONDON, Dec 5 (Reuters) - European shares see-sawed on Tuesday with sectors strongly diverging as a rotation from tech stocks into financials, bolstered by the U.S. tax bill, gathered pace.

businessNews reuters.com

Asian shares down as tech blues offset U.S. tax cut optimism

TOKYO (Reuters) - Asian shares dipped slightly on Tuesday as investors' rotation out of technology shares took a toll on some of the region's tech heavyweights although hopes of a major tax cut in the United States underpinned risk sentiment.

companyNews reuters.com

GLOBAL MARKETS-Asian shares down as tech blues offset U.S. tax cut optimism

* Investors rotate to banks and other beneficiaries of lower tax

companyNews reuters.com

Nikkei slips as tech shares follow U.S. counterparts down

TOKYO, Dec 5 (Reuters) - Japan's Nikkei share average dropped on Tuesday with semiconductor equipment manufacturers' stocks hit by weakness in U.S. tech shares overnight, undercutting gains for banks and brokerages.

cnn.com

WaPo: Woman shares card she says Moore signed

Debbie Wesson Gibson, a woman who says she knew Alabama GOP Senate candidate Roy Moore when she was 17 years old, shares a signed card taped to her senior yearbook, according to the Washington Post.

businessNews reuters.com

Asian shares muted as tech blues offset U.S. tax cut optimism

TOKYO (Reuters) - Asian shares were subdued on Tuesday as investors' rotation out of technology shares took a toll on some of the region's tech heavyweights although hopes of a major tax cut in the United States underpinned risk sentiment.

companyNews reuters.com

GLOBAL MARKETS-Asian shares muted as tech blues offset U.S. tax cut optimism

* Investors rotate to banks and other beneficiaries of lower tax

companyNews reuters.com

Nikkei falls hit by tech shares, offsets gains in financials

TOKYO, Dec 5 (Reuters) - Japan's Nikkei share average dropped on Tuesday morning with semiconductor equipment manufacturers' stocks hit by weakness in U.S. tech shares overnight, undercutting gains in financial stocks as banks and brokers.

companyNews reuters.com

Trial results of Zika vaccine Sanofi dropped show promise

CHICAGO, Dec 4 (Reuters) - A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday.

companyNews reuters.com

BRIEF-Vornado Announces Public Offering Of $300 Mln 5.25% Series M Cumulative Redeemable Preferred Shares

* VORNADO ANNOUNCES PUBLIC OFFERING OF $300 MILLION 5.25% SERIES M CUMULATIVE REDEEMABLE PREFERRED SHARES

businessNews reuters.com

Asian shares subdued as tech blues offset U.S. tax cut hopes

TOKYO (Reuters) - Asian shares were subdued on Tuesday as investors' rotation out of technology shares took the toll on some of the region's tech heavyweights although hopes of a major tax cut in the United States underpinned risk sentiment.

companyNews reuters.com

GLOBAL MARKETS-Asian shares subdued as tech blues offset U.S. tax cut hopes

* Investors rotate to banks and other beneficiaries of lower tax

cnn.com

Drugmaker paid doctors with problem records to promote its pill

One physician had his prescription pad taken away after he repeatedly failed tests assessing his competency.

businessNews reuters.com

Mastercard to repurchase up to $4 billion of its shares

(Reuters) - Payment processor Mastercard Inc said on Monday it would buy back up to $4 billion of its class A shares.

companyNews reuters.com

BRIEF-Godaddy Inc. Announces Proposed Sale Of Shares Of Common Stock

* GODADDY INC. ANNOUNCES PROPOSED SALE OF SHARES OF COMMON STOCK

healthNews reuters.com

Court-mandated opioid rehab rarely meets medical standards

(Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts receive methadone or buprenorphine, two drugs doctors consider the best treatment option, a U.S. study suggests.

companyNews reuters.com

MOVES-Northern Trust names Dan Madden ETF Capital Markets head for FlexShares

Dec 4 (Reuters) - Wealth management firm Northern Trust Corp said on Monday it had hired Dan Madden as head of ETF Capital Markets for FlexShares.

healthNews reuters.com

Montana sues OxyContin maker Purdue over opioid epidemic

(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.

healthNews reuters.com

Trouble mounts for Sanofi dengue vaccine over safety concerns

(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases.

healthNews reuters.com

Tattooed wish for withholding treatment not good enough, doctors say

(Reuters Health) - Consumers are often told, "Put it in writing." But in the case of a hospitalized Florida man facing death, displaying his wish by having it tattooed on his chest wasn't good enough.

companyNews reuters.com

BRIEF-Newmark Group Sees IPO Of 30 Mln Shares Of Class A Common Stock Priced Between $19 And $22 Per Share

* NEWMARK GROUP INC SEES IPO OF 30.0 MILLION SHARES OF CLASS A COMMON STOCK PRICED BETWEEN $19 AND $22 PER SHARE - SEC FILING​

healthNews reuters.com

Healthcare prices hard to find online

Reuters Health - Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. study suggests.

healthNews reuters.com

Sanofi says monitoring outcomes of ongoing dengue vaccination schemes

PARIS (Reuters) - Sanofi on Monday said it was monitoring outcomes of ongoing public programs involving its dengue vaccine, Dengvaxia, following the launch of a probe in the Philippines.

businessNews reuters.com

Shares of big U.S. banks jump as Senate approves tax overhaul

(Reuters) - Shares of the biggest U.S. banks rose on Monday, after the Senate approved a tax overhaul bill on Saturday, raising investor hopes that their earnings would get a boost from a significantly lower tax bill.

healthNews reuters.com

WHO reviewing data on Sanofi dengue vaccine, urges limited use

GENEVA (Reuters) - The World Health Organization (WHO) said on Monday it hoped to conduct a "full review" by year-end of data on Sanofi's dengue vaccine Dengvaxia.

healthNews reuters.com

Poor regulation, dodgy pills spur plan for African drugs agency

LONDON (Reuters) - Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus medicines found all too often in Africa.

healthNews reuters.com

Brazil recommends restrictions on Sanofi dengue vaccine

BRASILIA (Reuters) - The Brazilian government said on Monday it has suggested restrictions on the use of a dengue vaccine that has been suspended elsewhere after French drug company Sanofi SA said it could worsen the disease in some cases.

companyNews reuters.com

BRIEF-Medical Transcription Billing CEO Mahmud Ul Haq Reports Open Market Purchase Of 30,000 Shares Of Common Stock

* MEDICAL TRANSCRIPTION BILLING CEO MAHMUD UL HAQ REPORTS OPEN MARKET PURCHASE OF 30,000 SHARES OF CO'S COMMON STOCK ON DEC 1 AT 2.93 PER SHARE - SEC FILING‍​ Source text: (http://bit.ly/2jNvmdb) Further company coverage: